Method of preventing nmda receptor-mediated neuronal damage

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2143752

Disclosed is a method for reducing non-ischemic NMDA receptor-mediated neuronal damage in a mammal by administering to the mammal a compound of the formula shown in Fig. 1 (or a physiologically- acceptable salt thereof), wherein R1 includes an amino group, R2-R17 are independently H or a short chain aliphatic group comprising 1-5 carbons, and R4 and R10 also may (independently) be a halogen or an acyl group. Also disclosed is a screen for antagonists of NMDA receptor mediated neurotoxicity which have an enhanced prospect for being clinically tolerated and selective against such neurotoxicity.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of preventing nmda receptor-mediated neuronal damage does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preventing nmda receptor-mediated neuronal damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing nmda receptor-mediated neuronal damage will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1665282

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.